Nombre del producto:Bis(4-methoxybenzyl)amine

IUPAC Name:bis[(4-methoxyphenyl)methyl]amine

CAS:17061-62-0
Fórmula molecular:C16H19NO2
Pureza:95%+
Número de catálogo:CM118017
Peso molecular:257.33

Unidad de embalaje Stock disponible Precio($) Cantidad
CM118017-100g in stock Ƅǵ
CM118017-500g in stock NJƞƄ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :17061-62-0
Fórmula molecular:C16H19NO2
Punto de fusión:-
Código de sonrisas:COC1=CC=C(C=C1)CNCC2=CC=C(OC)C=C2
Densidad:
Número de catálogo:CM118017
Peso molecular:257.33
Punto de ebullición:
Nº Mdl:MFCD00277836
Almacenamiento:

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Nitrogen Compounds
Nitrogen compounds can be classified as mineral or organic. Mineral compounds are essentially formed by the ammonium ion (NH4+), which is generated when ammonium salts are dissolved in water. Organic compounds, in contrast, are carbon and hydrogen compounds that contain a nitrogen atom. All organic nitrogen-containing compounds can be considered as derivatives of ammonia in which one or more hydrogen atoms are substituted by hydrocarbon radicals.
Tolebrutinib
Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis(nrSPMS).
Tolebrutinib is an investigational, oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase (BTK) inhibitor that achieves CSF concentrations predicted to modulate B lymphocytes and disease-associated microglia.

Related Products